With elderly cancer cases rising, Indigests 60-plus therapy model
A “60-plus therapy model” for older cancer patients is described as geriatric oncology-focused care rather than one-size-fits-all standard regimens.
- Geriatric oncology means cancer care designed for ageing-related changes in the body and daily functioning.
- Functional status means how well a person can do daily activities; in cancer care, it helps decide how therapy may be tolerated.
- Comorbidity means more than one medical condition together; in older cancer care, comorbidity can affect treatment choices and side-effect risk.
- The 60-plus therapy model emphasises age-adapted treatment instead of applying standard regimens uniformly to older adults.
What happened: A “60-plus therapy model” for older cancer patients
A health feature describes rising cancer incidence among people aged 60 and above and frames geriatric oncology as an emerging care need. The feature presents a “60-plus therapy model” aimed at improving outcomes for older patients by tailoring cancer treatment to age-related risks rather than applying standard cancer regimens uniformly.
The model is described around three linked priorities in cancer care for older adults: fitness-for-therapy assessment (whether an older patient can safely tolerate planned treatment), care coordination (aligning different care steps across the therapy pathway), and toxicity management (monitoring and managing treatment side effects to support safer continuity of evidence-based treatment).
UPSC can frame geriatric oncology as a question of health governance at the bedside: how clinicians and health systems assess therapy tolerance, coordinate services across the care pathway, and manage side effects in older adults.
